Method for identifying type I diabetes mellitus in humans
Abstract
A method and system for classifying subject populations utilizing predictive and diagnostic biomarkers for type I diabetes mellitus. The method including determining the levels of a variety of markers within the serum or plasma of a target organism and correlating this level to general populations as a screen for predisposition or progressive monitoring of disease presence or predisposition.
- Inventors:
-
- Kennewick, WA
- Richland, WA
- Pasco, WA
- Issue Date:
- Research Org.:
- Pacific Northwest National Laboratory (PNNL), Richland, WA (United States)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1016737
- Patent Number(s):
- 7923253
- Application Number:
- US Patent Application 12/291,173
- Assignee:
- Battelle Memorial Institute (Richland, WA)
- Patent Classifications (CPCs):
-
G - PHYSICS G01 - MEASURING G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- DOE Contract Number:
- AC05-76RLO1830
- Resource Type:
- Patent
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 60 APPLIED LIFE SCIENCES
Citation Formats
Metz, Thomas O, Qian, Weijun, Jacobs, Jon M, and Smith, Richard D. Method for identifying type I diabetes mellitus in humans. United States: N. p., 2011.
Web.
Metz, Thomas O, Qian, Weijun, Jacobs, Jon M, & Smith, Richard D. Method for identifying type I diabetes mellitus in humans. United States.
Metz, Thomas O, Qian, Weijun, Jacobs, Jon M, and Smith, Richard D. Tue .
"Method for identifying type I diabetes mellitus in humans". United States. https://www.osti.gov/servlets/purl/1016737.
@article{osti_1016737,
title = {Method for identifying type I diabetes mellitus in humans},
author = {Metz, Thomas O and Qian, Weijun and Jacobs, Jon M and Smith, Richard D},
abstractNote = {A method and system for classifying subject populations utilizing predictive and diagnostic biomarkers for type I diabetes mellitus. The method including determining the levels of a variety of markers within the serum or plasma of a target organism and correlating this level to general populations as a screen for predisposition or progressive monitoring of disease presence or predisposition.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2011},
month = {4}
}
Works referenced in this record:
Increased plasma corticosteroid-binding globulin in insulin-dependent pubertal diabetics: Relationships with other glycoproteins, growth hormone and prolactin
journal, October 1979
- Angeli, Alberto; Ramenghi, Ugo; Bello, Stefania
- Acta Diabetologica Latina, Vol. 16, Issue 4
Salivary protein profiling in type I diabetes using two-dimensional electrophoresis and mass spectrometry
journal, March 2006
- Hirtz, Christophe; Chevalier, François; Sommerer, Nicolas
- Clinical Proteomics, Vol. 2, Issue 1-2